Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

Presentation

Switching of OAC After PCI in A-fib Patients:RE-DUAL PCI Trial Subanalysis

December 04, 2019

News Daily News

Switch Anticoagulants for A-fib Patients Needing a Stent? RE-DUAL PCI Insights

Shelley Wood

December 02, 2019

News Daily News

Anticoagulant Type May Influence Fracture Risk in A-fib Patients

Todd Neale

October 21, 2019

Presentation TCT 2019

Approaches to Reduce Bleeding Risk Post PCI in Patients Requiring OAC: Is There Any Role for ASA?

Presenter: C. Michael Gibson

September 28, 2019

Presentation TCT 2019

When and How to Switch to OAC Alone After PCI?

Presenter: Manesh Patel

September 27, 2019

Presentation TCT 2019

PCI in Patients Requiring OAC: Which OAC and in Whom?

Presenter: Davide Capodanno

September 27, 2019

Debate: Dual Therapy (OAC+SAPT) Should Be the Default Therapy at Discharge in Most Patients - Pro: Dual Therapy (OAC+SAPT) Should Be the Default Therapy at Discharge in Most Patients

Presentation TCT 2019

Pro: Dual Therapy (OAC+SAPT) Should Be the Default Therapy at Discharge in Most Patients

Presenter: C. Michael Gibson

September 27, 2019

News Conference News ESC 2019

AFIRE Supports Rivaroxaban Monotherapy in A-fib Patients With Stable CAD

Todd Neale

September 02, 2019

News Daily News

Oral Anticoagulation Post-AVR Safe but Not Routinely Needed: PARTNER II

Caitlin E. Cox

August 27, 2019

News Daily News

Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data

Caitlin E. Cox

August 21, 2019

News Industry News

Boston Scientific Initiates Trial Comparing Left Atrial Appendage Closure to Direct Oral Anticoagulants for Stroke Risk Reduction Post-AFib Ablation

May 22, 2019

News Conference News EHRA 2019

Edoxaban Joins Other NOACs as Option During Catheter Ablation for A-fib

Todd Neale

March 21, 2019

Advertisement

Switching of OAC After PCI in A-fib Patients:RE-DUAL PCI Trial Subanalysis

Switch Anticoagulants for A-fib Patients Needing a Stent? RE-DUAL PCI Insights

Anticoagulant Type May Influence Fracture Risk in A-fib Patients

Approaches to Reduce Bleeding Risk Post PCI in Patients Requiring OAC: Is There Any Role for ASA?

When and How to Switch to OAC Alone After PCI?

PCI in Patients Requiring OAC: Which OAC and in Whom?

Pro: Dual Therapy (OAC+SAPT) Should Be the Default Therapy at Discharge in Most Patients

AFIRE Supports Rivaroxaban Monotherapy in A-fib Patients With Stable CAD

Oral Anticoagulation Post-AVR Safe but Not Routinely Needed: PARTNER II

Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data

Boston Scientific Initiates Trial Comparing Left Atrial Appendage Closure to Direct Oral Anticoagulants for Stroke Risk Reduction Post-AFib Ablation

Edoxaban Joins Other NOACs as Option During Catheter Ablation for A-fib

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content